"renal carcinoma" trang 8 - tải miễn phí từ tailieuXANH
Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients

Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
11    127    1
Significance of PD-L1 expression in tongue cancer development

Significance of PD-L1 expression in tongue cancer development
8    69    0
Efficacy of sorafenib in BRAF-mutated nonsmall-cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report

Efficacy of sorafenib in BRAF-mutated nonsmall-cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report
5    46    0
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: Over 10 years of experience

Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: Over 10 years of experience
8    51    0
Ebook Imaging for surgical disease: Part 2

Ebook Imaging for surgical disease: Part 2
222    39    0
Surgery of nephron-sparing: Part 1

Surgery of nephron-sparing: Part 1
97    69    0
Urogenital imaging and direct diagnosis in radiology: Part 1

Urogenital imaging and direct diagnosis in radiology: Part 1
156    55    0
Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma
12    158    0
Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer

Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer
7    64    0
Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas

Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas
13    57    0
PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in firstline treatment of patients with advanced or metastatic renal cell carcinoma

PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in firstline treatment of patients with advanced or metastatic renal cell carcinoma
9    71    0
Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma
12    65    0
Early assessment with 18F-2-fluoro-2- deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Early assessment with 18F-2-fluoro-2- deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab
9    66    0
Periodontology at a Glance (1st Edition): Part 1

Periodontology at a Glance (1st Edition): Part 1
56    74    0
ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma

ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma
7    73    0
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
15    81    0
Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients

Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients
10    91    0
Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study

Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study
10    58    0
Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer

Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
14    73    1
Older renal cell cancer patients experience increased rates of venous thromboembolic events: A retrospective cohort study of SEER-Medicare data

Older renal cell cancer patients experience increased rates of venous thromboembolic events: A retrospective cohort study of SEER-Medicare data
10    65    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.